Principal Financial Group Inc Novo Cure LTD Transaction History
Principal Financial Group Inc
- $172 Billion
- Q4 2024
A detailed history of Principal Financial Group Inc transactions in Novo Cure LTD stock. As of the latest transaction made, Principal Financial Group Inc holds 9,134 shares of NVCR stock, worth $216,932. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,134Holding current value
$216,932% of portfolio
0.0%Shares
28 transactions
Others Institutions Holding NVCR
# of Institutions
264Shares Held
76.5MCall Options Held
1.17MPut Options Held
318K-
Black Rock Inc. New York, NY12.1MShares$288 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$281 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$188 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA4.31MShares$102 Million0.01% of portfolio
-
Nordwand Advisors, LLC Radnor, PA3.03MShares$72 Million12.67% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.49B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...